Subgroup Analyses of the REDUCE LAP-HF II Study of the Corvia Atrial Shunt

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Grant Support/Research Contract (Personal) - Axon; AstraZenca; Corvia; Medtronic; GlaxoSmithKline; Tenax
• Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Amgen; Aria; Boehringer Ingelheim; Edwards Lifesciences; Eli Lilly; Imbria; Janssen; Novo Nordisk; VADovations